Effects of TIcaGREloR on Circulating Microparticles and Micro-RNAs in Patients With Non ST Elevation Acute Coronary Syndromes
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Biomarker; Pharmacodynamics
- Acronyms TIGER-M
- 15 Nov 2017 Results presented at the 90th Annual Scientific Sessions of the American Heart Association
- 25 Jul 2016 Planned End Date changed from 1 Apr 2015 to 1 Nov 2016.
- 25 Jul 2016 Status changed from completed to discontinued.